Danaher Co. (NYSE:DHR) Stock Position Reduced by Roffman Miller Associates Inc. PA

Roffman Miller Associates Inc. PA lessened its holdings in Danaher Co. (NYSE:DHRFree Report) by 1.8% in the third quarter, HoldingsChannel.com reports. The firm owned 41,788 shares of the conglomerate’s stock after selling 757 shares during the period. Roffman Miller Associates Inc. PA’s holdings in Danaher were worth $11,618,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. LVW Advisors LLC grew its position in Danaher by 30.6% in the 2nd quarter. LVW Advisors LLC now owns 1,229 shares of the conglomerate’s stock worth $307,000 after purchasing an additional 288 shares during the last quarter. Alpha Cubed Investments LLC acquired a new stake in Danaher in the 2nd quarter valued at approximately $277,000. Sequoia Financial Advisors LLC raised its stake in Danaher by 4.1% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 19,276 shares of the conglomerate’s stock valued at $4,816,000 after acquiring an additional 751 shares in the last quarter. Wedmont Private Capital boosted its position in Danaher by 7.9% during the 2nd quarter. Wedmont Private Capital now owns 4,736 shares of the conglomerate’s stock worth $1,168,000 after acquiring an additional 345 shares during the period. Finally, Roman Butler Fullerton & Co. grew its stake in shares of Danaher by 5.3% in the second quarter. Roman Butler Fullerton & Co. now owns 1,314 shares of the conglomerate’s stock worth $318,000 after purchasing an additional 66 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on DHR shares. Royal Bank of Canada reduced their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Thursday. Evercore ISI raised their price objective on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Stifel Nicolaus upped their target price on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Finally, Stephens reiterated an “overweight” rating and set a $315.00 price target on shares of Danaher in a research report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Check Out Our Latest Stock Analysis on Danaher

Danaher Trading Up 1.0 %

NYSE:DHR opened at $230.12 on Monday. The stock’s 50 day moving average price is $250.76 and its 200 day moving average price is $258.32. Danaher Co. has a 52 week low of $215.68 and a 52 week high of $281.70. The company has a market capitalization of $166.21 billion, a P/E ratio of 43.92, a P/E/G ratio of 4.23 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the previous year, the company earned $2.02 EPS. On average, research analysts forecast that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.47%. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.